A Risk Evaluation and Mitigation Strategy (REMS) is an FDA-mandated approach to ensuring the safety of medications. The baseline for ensuring the safe use of prescribed medication is professional labelling. REMS applies to situations where professional labelling is considered inadequate to ensure the safe use of a drug or class of drugs.
Revolutionizing Today’s Clinical Trial Using Adherence Intelligence The Latest
Since 2001, Information Mediary Corporation (IMC) remains the global leader in providing real-time remote patient monitoring solutions that identify poor medication-taking behavior. Patented ECM®s (electronic compliance monitors) employ smart sensor technologies designed for use with pill caps and blister packs that record the date and time of dose removal. Adherence monitoring enables efficient, accurate medication management; a significant breakthrough in the pharmaceutical industry. IMC uses time-stamped features with its ECM® solutions to feed objective adherence data to its analytics and documentation platform, CertiScan®. The CertiScan® platform provides powerful visualizations for clinical research teams that drive actionable insights, prompt behavioral intervention and improve patient health outcomes that reduce trial costs, streamline supply chain management, lower waste and expedite document reconciliation for submission to the FDA.
